Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-12 of 12 for your search:
Start Over
Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China
Phase: Phase IV
Type: Prevention
Status: Approved-not yet active
Age: 13 to 15
Sponsor: Other
Protocol IDs: 37207, NCT01021904
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Phase: Phase IV
Type: Prevention
Status: Active
Age: 15 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 109823, 2013-003429-28, NCT01031069
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
Phase: Phase IV
Type: Prevention
Status: Active
Age: 11 to 17
Sponsor: Other
Protocol IDs: GardasilMerckGomez-Lobo, NCT01101750
Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study
Phase: Phase IV
Type: Prevention
Status: Active
Age: 18 to 26
Sponsor: Other
Protocol IDs: CIHR-MOP-125949, IIS #38265, NCT01824537
HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Phase: Phase III
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NL45200.018.13, NCT02087384
Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City
Phase: Phase III
Type: Prevention
Status: Active
Age: 10 to 11
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: 091-2014, NCT02382900
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 13 to 26
Sponsor: NCI, Other
Protocol IDs: AMC-072, U01CA121947, CDR0000685816, NCT01209325
Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention
Phase: No phase specified
Type: Health services research, Prevention
Status: Active
Age: 9 to 13
Sponsor: Other
Protocol IDs: 36448, NCT01096134
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
Phase: No phase specified
Type: Health services research, Prevention, Screening
Status: Active
Age: 18 to 26
Sponsor: Other
Protocol IDs: 33249, NCT01133509
The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 26
Sponsor: Other
Protocol IDs: 2011/02_Medicine, NCT01298869
3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in China
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Approved-not yet active
Age: 9 to 45
Sponsor: Other
Protocol IDs: V501-030-1, NCT01427777
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: 9 to 17
Sponsor: NIAID
Protocol IDs: 08-0012, N01AI80006C, NCT01030562
Start Over